Evidence for Sensory Neuropathy and Pharmacologic Management

Otolaryngologic Clinics of North America

Volumn 43, Issue 1, 2010, Pages 67-72

  Greene, Scott M ^a   Simpson, C Blake ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Chronic cough; Irritable larynx; Laryngeal sensory neuropathy; Postviral vagal neuropathy

Indexed keywords

AMITRIPTYLINE; GABAPENTIN; PREGABALIN;

BLURRED VISION; CLINICAL EVALUATION; COUGHING; DISEASE ASSOCIATION; DIZZINESS; DRUG DOSE INCREASE; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DYSPHAGIA; DYSPHONIA; HUMAN; LARYNGEAL NERVE; LARYNGOPHARYNGEAL REFLUX; MOTOR DYSFUNCTION; ODYNOPHAGIA; PERIPHERAL EDEMA; POSTVIRAL VAGAL NEUROPATHY; REVIEW; SENSORY DYSFUNCTION; SENSORY NEUROPATHY; SIDE EFFECT; SOMNOLENCE; VAGUS NERVE; VIRUS INFECTION; VOCAL CORD PARALYSIS; WEIGHT GAIN; XEROSTOMIA;

ADRENERGIC UPTAKE INHIBITORS; AMINES; AMITRIPTYLINE; ANTICONVULSANTS; CHRONIC DISEASE; COUGH; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; VAGUS NERVE DISEASES; VIRUS DISEASES;

EID: 76749101242     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2009.11.003     Document Type: Review

References (14)

1. Irwin R.S., Curley F.J., and French C.L. Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 141 (1990) 640-647
2. Morrison M., Rammage L., and Emami A.J. The irritable larynx syndrome. J Voice 13 (1999) 447-455
3. Jeyakumar A. Effectiveness of amatriptyline versus cough suppressants in the treatement of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 116 (2006) 2108-2112
4. Lee B., and Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol 114 (2005) 253-257
5. Bastian R.W., Vaidya A.M., and Delsupehe K.G. Sensory neuropathic cough: a common and treatable cause of cough. Otolaryngol Head Neck Surg 135 (2006) 17-21
6. Amin M.R., and Koufman J.A. Vagal neuropathy after upper respiratory infections: a viral etiology?. Am J Otolaryngol 22 (2001) 251-256
7. Rees C.J., Henderson A.H., and Belafsky P.C. Postviral vagal neuropathy. Ann Otol Rhinol Laryngol 118 4 (2009) 247-252
8. Irwin R., Boulet L., Cloutier M., et al. Managing cough as a defense mechanism and as a symptom: a consensus report of the American College of Chest Physicians. Chest 144 2 Suppl Managing (1998) 133S-181S
9. Pregabalin: In: DRUGDEX System [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare) Inc. Updated periodically.
10. Halum S.L., Sycamore D.L., and McRae B.R. A new treatment option for laryngeal sensory neuropathy. Laryngoscope (2009)
11. Freynhagen R., Strojek K., Griesing T., et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of fble- and fixed-dose regimens. Pain 115 3 (2005) 254-263
12. Wesche D., and Bockbrader H. A pharmacokinetic comparison of pregabalin and gabapentin. The Journal of Pain 6(3) Suppl 1 (2005) S29
13. Gabapentin. In: DRUGDEX System [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare) Inc. Updated periodically.
14. Amitryptline. In: DRUGDEX System [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare) Inc. Updated periodically.